Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as part of the pineal bioregulator series. It mimics the active core of natural pineal peptides, supporting investigations into neuronal survival, BDNF expression, and epigenetic regulation in brain tissue. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation. For Research Use Only. Not for human use.
Key Scientific Attributes
- High-purity Pinealon (≥99% by HPLC/MS, acetate salt form)
- Verified tripeptide sequence: Glu-Asp-Arg (EDR)
- Lyophilized formulation for maximum long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis
- Manufactured in GMP-aligned, ISO-compliant facilities
- Suitable for neuroprotection pathway studies, BDNF modulation research, and pineal/circadian biology investigations
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
- Studied for effects on neuronal survival and oxidative stress responses in in vitro culture models
- Investigated for effects on pineal function and melatonin secretion in aged animal models
- Used in studies examining epigenetic changes and hippocampal neurogenesis in animal models
- Subject of in vitro and preclinical research across neuroscience and gerontology disciplines
Why Researchers Choose Nationwide Peptides Pinealon
- Exact Khavinson-sequence match used in 30+ years of published bioregulator studies
- Transparent analytical data (HPLC >99%, MS confirmation)
- Utilized in neuroscience, gerontology, and cell biology research laboratories
- Competitive research pricing with bulk options
